Epilepsy in children with attention deficit disorder: cognitive, behavioral, and neuroanatomic indices

Evaluation of the Nutritional Status in Institutionalized Children and its Relationship to the Development of Epilepsy

Malnutrition as defined by the World Health Organization (WHO) in 1973 is an association of pathologic conditions caused by a lack of calories or protein intake in variable proportions. It is still one of the leading causes of infant mortality in developing countries. Risk factors for early malnutrition are absence of perinatal care and low birth weight. Epilepsy is also a very prevalent condition in childhood. A relationship between malnutrition and epilepsy has been suggested in many basic studies but it has never been proven in humans. In order to verify if malnutrition can lead to epilepsy, we reviewed anthropometric and medical files from infants in a governmental institution and tried to relate to an outcome of epilepsy. We defined malnutrition as height/weight below two pattern deviations from the NCHS tables. Two hundred and forty three children were included, 101 with malnutrition and 133 nourished. Our results indicate a predominance of malnutrition in girls (49%) and a comorbidity of malnutrition and neurological disorders. Although there were more cases of epilepsy in the malnourished group, the difference was not significant, and we could not assume that malnutrition was the cause of epilepsy in these cases because of the association of many other diseases that could also damage the central nervous system.

Neuropsychological endophenotypes in ADHD with and without epilepsy

Attention-deficit hyperactivity disorder (ADHD) is a frequent comorbidity in children with epilepsy. Despite similarities in behavioral manifestations of inattention and hyperactivity, it is unclear whether the neuropsychological endophenotypes of children with developmental ADHD differ from those with ADHD in the context of epilepsy. The present study compared groups of clinically referred children with both ADHD-Inattentive subtype (ADHD-I) and ADHD-Combined subtype (ADHD-C) to children with ADHD-I and ADHD-C and epilepsy on neuropsychological measures of intellectual functioning, auditory attention, working memory, and sustained attention and response inhibition. Those with ADHD and epilepsy performed more poorly on measures of intellectual function (e.g., Full-Scale IQ, Verbal IQ, Performance IQ) as well as auditory attention and working memory. Differences across the groups were also seen on a continuous performance test. Follow-up correlational analyses showed that variables such as seizure frequency and number of antiepilepsy medications predicted cognitive dysfunction in the epilepsy groups. Overall results suggest that the neuropsychological endophenotypes in developmental ADHD versus ADHD in epilepsy differ with seizure-related variables predicting cognitive dysfunction.

Attention deficit disorder and epilepsy

Countless studies have demonstrated that patients with epilepsy have a significant increase in behavioral disturbances of all kinds, including hyperactivity and inattention. This finding has been demonstrated in studies utilizing observer questionnaires and behavior rating scales, neuropsychological test batteries, and standardized tests of attention such as continuous performance tests. Multiple factors must be considered in the evaluation of a child with epilepsy and hyperactivity or inattention. For instance, inattention could be due to subclinical seizures, undiagnosed learning disabilities, disturbed sleep as a result of a side effect of antiepileptic medication, or due to an attention deficit disorder. Electroencephalographic monitoring is helpful to distinguish between behavioral inattention and partial complex or absence seizures. Electroencephalographic monitoring can also assess subclinical spike frequency, which may affect attention and other aspects of cognitive functioning in various ways, even in the absence of clinical seizures. Most antiepileptic drugs do not adversely affect attention and behavior in therapeutic doses, with the exception of phenobarbital, gabapentin, and topiramate. Some antiepileptic drugs, such as lamotrigine and carbamazepine, may even have beneficial effects. The preponderance of evidence suggests that stimulants other than bupropion are safe and effective in the treatment of attention deficit disorder in children with epilepsy, although controlled studies of dextroamphetamine in this population are lacking. So far, atomoxetine has not been demonstrated to have any adverse effect in children with epilepsy.